Sherie Morrison, Ph.D.

University of California, Los Angeles
email: sheriem@microbio.ucla.edu

Grants

Antibody Fusion Proteins for the Therapy of Breast Cancer 1997 (Cycle III)
ITaMoCAs 3CB-0245 $193,224


A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity
  Periodical: Journal of Immunology
  Author(s): Peng LS, Penichet ML, Morrison SL
  Yr: 1999 Vol: 163 Nbr: 1 Pgs: 250-8
  Associated Grant: Antibody Fusion Proteins for the Therapy of Breast Cancer
 
In vivo properties of three human HER2/nue expressing murine cell lines in immunocompetent mice
  Periodical: Lab Anim Sci
  Author(s): Penichet ML, Challita PM, Shin SU, Sampogna SL, Rosenblatt JD, Morrison SL
  Yr: 1999 Vol: 49 Nbr: 2 Pgs: 179-88
  Associated Grant: Antibody Fusion Proteins for the Therapy of Breast Cancer
 
A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway
  Periodical: Journal of Immunology
  Author(s): Challita-Eid PM, Penichet ML, Shin S-U, Poles T, Mosammaparast N, and Morrison SL
  Yr: 1998 Vol: 160 Nbr: Pgs: 3419-3426
  Associated Grant: Antibody Fusion Proteins for the Therapy of Breast Cancer
 
An IgG3-IL2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and anti-tumor activity
  Periodical: Journal of Interferon and Cytokine Research
  Author(s): Penichet ML, Harvill ET, and Morrison SL
  Yr: 1998 Vol: 18 Nbr: 8 Pgs: 597-607
  Associated Grant: Antibody Fusion Proteins for the Therapy of Breast Cancer
 
A RANTES-antibody fusion protein retains antigen specificity and chemokine function.
  Periodical: Journal of Immunology
  Author(s): Challita-Eid PM, Abboud CN, Morrison SL, Penichet ML, Rosell KE, Poles T, Hilchey, et al.
  Yr: 1998 Vol: 161 Nbr: 7 Pgs: 3729-36
  Associated Grant: Antibody Fusion Proteins for the Therapy of Breast Cancer